Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04974216
Title Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications
Therapies
Age Groups: senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
Clinique Universitaire Saint LUC Brussels Belgium Details
CHU de Liège Liège Belgium Details
CHRU Mont Godinne Yvoir Belgium Details
CHU de Bordeaux - Hôpital Haut Lévêque Bordeaux France Details
Institut Bergonié - Bordeaux Bordeaux France Details
CH Saint Vincent de Paul Lille France Details
CHRU de LILLE - Claude Huriez Lille France Details
Chu de Limoges - Hopital Dupuytren Limoges France Details
CHU de Nantes - Hôtel Dieu Nantes France Details
Centre Antoine Lacassagne Nice France Details
APHP - Hôpital Saint Louis Paris France Details
Centre Henri Becquerel Rouen France Details
Centre René Huguenin - Institut Curie Saint-Cloud France Details
Institut de Cancérologie de la Loire Lucien Neuwirth Saint-Priest-en-Jarez 42270 France Details
CHU Brabois Vandoeuvre les Nancy France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field